Abstract

Scientific Goals The mission of the HDFCCC Tobacco Control (TO) Program is to reduce the burden of cancer caused by tobacco, locally, in the catchment area, and globally. This mission is advanced through robust Program themes reaching from the molecular level of tobacco-induced disease, to the physical and medical health effects of tobacco, to individual and community tobacco cessation efforts, and to policy and regulatory actions at state, national, and global levels. Theme 1: Biological determinants of tobacco-induced addiction and disease Theme 2: Social and behavioral determinants and interventions for tobacco addiction Theme 3: The tobacco industry as a disease vector and strategies to block it TO Program: Key Metrics Membership (9 departments, 4 schools) 28 Full 14 Associate 14 Cancer-relevant Funding (direct costs as of $9,353,958 05/31/2017) NCI $2,506,751 27% Peer-reviewed $4,804,645 51% Non-peer-reviewed $2,042,562 22% Cancer-relevant Publications (1/2012-7/2017) 492 Inter-programmatic 16 3% Intra-Programmatic 127 26% High-Impact 255 52% Accruals to Clinical Trials (2016) 7350 20 Therapeutic 0 0 Other Interventional 75 4 Non-interventional 7275 16

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA082103-19S2
Application #
9784163
Study Section
Subcommittee I - Transistion to Independence (NCI)
Program Officer
Shafik, Hasnaa
Project Start
Project End
Budget Start
2018-06-01
Budget End
2019-05-31
Support Year
19
Fiscal Year
2018
Total Cost
Indirect Cost

  Institution

Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118

  Publications

Tat, David; Kenfield, Stacey A; Cowan, Janet E et al. (2018) Milk and other dairy foods in relation to prostate cancer recurrence: Data from the cancer of the prostate strategic urologic research endeavor (CaPSURE™). Prostate 78:32-39
Guydish, Joseph; Tajima, Barbara; Le, Thao et al. (2018) Do cigarette graphic warnings encourage smokers to attend a smoking cessation programme: a quasi-experimental study. Tob Control 27:43-49
Dvorak, Christopher C; Satwani, Prakash; Stieglitz, Elliot et al. (2018) Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study. Pediatr Blood Cancer 65:e27034
Fan, Qi Wen; Nicolaides, Theodore P; Weiss, William A (2018) Inhibiting 4EBP1 in Glioblastoma. Clin Cancer Res 24:14-21
Sannino, Sara; Guerriero, Christopher J; Sabnis, Amit J et al. (2018) Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cells. J Cell Sci 131:
Lam, Christine; Ferguson, Ian D; Mariano, Margarette C et al. (2018) Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica 103:1218-1228
Truillet, Charles; Parker, Matthew F L; Huynh, Loc T et al. (2018) Measuring glucocorticoid receptor expression in vivo with PET. Oncotarget 9:20399-20408
Phillips, Kathryn A; Trosman, Julia R; Deverka, Patricia A et al. (2018) Insurance coverage for genomic tests. Science 360:278-279
Phillips, Kathryn A (2018) Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning? JAMA 319:2379-2380
Puri, Sapna; Roy, Nilotpal; Russ, Holger A et al. (2018) Replication confers ? cell immaturity. Nat Commun 9:485

Showing the most recent 10 out of 192 publications